SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-10-033548
Filing Date
2010-06-15
Accepted
2010-06-15 16:03:24
Documents
5
Effectiveness Date
2010-06-15

Document Format Files

Seq Description Document Type Size
1 v188302_defa14a.htm DEFA14A 29883
2 GRAPHIC pc1.jpg GRAPHIC 136663
3 GRAPHIC pc2.jpg GRAPHIC 191955
4 GRAPHIC pc3.jpg GRAPHIC 107992
5 GRAPHIC pc4.jpg GRAPHIC 46566
  Complete submission text file 0001144204-10-033548.txt   697549
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: DEFA14A | Act: 34 | File No.: 000-25169 | Film No.: 10897484
SIC: 2834 Pharmaceutical Preparations